ARKG
- ARK Genomic Revolution ETFKey Information
| Earliest date | 2014-10-31 |
| Exchange | CBOE |
| Instrument Type | ETF |
| MIC Code | BATS |
| Country | United States |
ETF Information
| Fund Provider | ARK Invest |
| Index | Active (No Index) |
| Expense Ratio | 0.75% |
| Number Of Holdings | 42 |
| Inception Date | 2014-10-31 |
| Asset Class | Equity |
| Listing | US-listed |
| Sector | Healthcare |
| Investment Style | Growth |
| Non-leveraged | Non-leveraged |
About ARKG
The ARK Genomic Revolution ETF is an actively managed fund that invests in companies driving advancements in genomics, gene editing, genetic therapy, molecular diagnostics, and stem cell advances. The fund's portfolio is tilted towards smaller firms and is designed to capture long-term growth potential in the healthcare and biotechnology sectors.